(Bloomberg) -- Members of Congress are in an unusual position asthey demand an explanation for Mylan NV’s 400 percentprice hike for the EpiPen and focusattention squarely on its CEO: Heather Bresch.

If lawmakers follow the usual script, Bresch could getcalled up to Capitol Hill next month to explain her company’sjustification for raising the price on the life-saving allergyshot. But that could be awkward, since she’s the daughter ofDemocratic Senator Joe Manchin of West Virginia.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Voluntary Benefits
Consumer Driven Health Care
Cost-Containment
Wellness